JP2012520446A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012520446A5 JP2012520446A5 JP2011553450A JP2011553450A JP2012520446A5 JP 2012520446 A5 JP2012520446 A5 JP 2012520446A5 JP 2011553450 A JP2011553450 A JP 2011553450A JP 2011553450 A JP2011553450 A JP 2011553450A JP 2012520446 A5 JP2012520446 A5 JP 2012520446A5
- Authority
- JP
- Japan
- Prior art keywords
- monitoring
- biomarker
- cells
- methyl
- dim
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09154964.2 | 2009-03-12 | ||
| EP09154964 | 2009-03-12 | ||
| PCT/EP2010/053063 WO2010103058A1 (en) | 2009-03-12 | 2010-03-11 | Method or system using biomarkers for the monitoring of a treatment |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012520446A JP2012520446A (ja) | 2012-09-06 |
| JP2012520446A5 true JP2012520446A5 (cg-RX-API-DMAC7.html) | 2013-04-25 |
| JP5667581B2 JP5667581B2 (ja) | 2015-02-12 |
Family
ID=42129920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011553450A Expired - Fee Related JP5667581B2 (ja) | 2009-03-12 | 2010-03-11 | 治療をモニターするためのバイオマーカーを使用した方法またはシステム |
Country Status (24)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2669469T3 (es) * | 2008-06-06 | 2018-05-25 | Boehringer Ingelheim International Gmbh | Forma de dosificación farmacéutica en cápsula que comprende una formulación en suspensión de un derivado de indolinona |
| US20170065529A1 (en) | 2015-09-09 | 2017-03-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical dosage form for immediate release of an indolinone derivative |
| UA107560C2 (uk) * | 2008-06-06 | 2015-01-26 | Фармацевтична лікарська форма для негайного вивільнення похідної індолінону | |
| US20140350022A1 (en) | 2013-05-10 | 2014-11-27 | Boehringer Ingelheim International Gmbh | Efficacious treatment of NSCLC and predictive clinical marker of the responsiveness of a tumour to a treatment |
| CN104003925B (zh) * | 2013-06-05 | 2016-03-30 | 四川大学 | 吲哚酮化合物或其衍生物及其用途 |
| CA3172586C (en) | 2013-07-31 | 2025-10-14 | Avalyn Pharma Inc. | IMATINIB AEROSOL COMPOUNDS AND RELATED USES |
| WO2018081236A1 (en) * | 2016-10-28 | 2018-05-03 | Cedars-Sinai Medical Center | Method of predicting progression of idiopathic pulmonary fibrosis and monitoring of therapeutic efficacy |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6762180B1 (en) * | 1999-10-13 | 2004-07-13 | Boehringer Ingelheim Pharma Kg | Substituted indolines which inhibit receptor tyrosine kinases |
| UA75054C2 (uk) | 1999-10-13 | 2006-03-15 | Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг | Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу |
| DE10233500A1 (de) * | 2002-07-24 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel |
| US20040204458A1 (en) * | 2002-08-16 | 2004-10-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of Lck inhibitors for treatment of immunologic diseases |
| DE10237423A1 (de) | 2002-08-16 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von LCK-Inhibitoren für die Behandlung von immunologischen Erkrankungen |
| US20050043233A1 (en) | 2003-04-29 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis |
| EP1571225A1 (en) | 2004-03-02 | 2005-09-07 | PrimaGen Holding B.V. | Diagnosis of a disease and monitoring of therapy using the AC133 gene |
| PE20060777A1 (es) * | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
| EP1777523A1 (en) | 2005-10-19 | 2007-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method |
| US8557531B2 (en) | 2006-04-18 | 2013-10-15 | Wellstat Biologics Corporation | Detection of circulating endothelial cells |
| EP1870400A1 (en) | 2006-06-08 | 2007-12-26 | Boehringer Ingelheim Pharma GmbH & Co. KG | Salts and crystalline salt forms of an 2-indolinone derivative |
| AU2007293280A1 (en) * | 2006-09-07 | 2008-03-13 | Astrazeneca Ab | Method for evaluating patients for treatment with drugs targeting RET receptor tyrosine kinase |
| KR20090128474A (ko) | 2007-04-13 | 2009-12-15 | 브리스톨-마이어스 스큅 컴퍼니 | 혈관 내피 성장인자 수용체-2 조절제에 대한 감수성을 판정하기 위한 방법 및 바이오마커 |
| US20100184049A1 (en) | 2007-04-27 | 2010-07-22 | Steve Goodison | Glycoprotein Profiling of Bladder Cancer |
-
2010
- 2010-03-09 US US12/720,663 patent/US8802384B2/en not_active Expired - Fee Related
- 2010-03-10 UY UY0001032482A patent/UY32482A/es not_active Application Discontinuation
- 2010-03-11 TW TW099107108A patent/TW201100802A/zh unknown
- 2010-03-11 AR ARP100100765A patent/AR076113A1/es unknown
- 2010-03-11 KR KR1020117021089A patent/KR20110137307A/ko not_active Withdrawn
- 2010-03-11 CA CA2755055A patent/CA2755055A1/en not_active Abandoned
- 2010-03-11 BR BRPI1011688A patent/BRPI1011688A2/pt not_active IP Right Cessation
- 2010-03-11 PE PE2011001619A patent/PE20120592A1/es not_active Application Discontinuation
- 2010-03-11 MX MX2011009482A patent/MX2011009482A/es active IP Right Grant
- 2010-03-11 EA EA201101300A patent/EA201101300A1/ru unknown
- 2010-03-11 EP EP10709198A patent/EP2406628A1/en not_active Withdrawn
- 2010-03-11 CN CN201080009568XA patent/CN102334030A/zh active Pending
- 2010-03-11 MA MA34165A patent/MA33120B1/fr unknown
- 2010-03-11 NZ NZ594843A patent/NZ594843A/en not_active IP Right Cessation
- 2010-03-11 WO PCT/EP2010/053063 patent/WO2010103058A1/en not_active Ceased
- 2010-03-11 AU AU2010223256A patent/AU2010223256B2/en not_active Ceased
- 2010-03-11 SG SG2011065224A patent/SG174324A1/en unknown
- 2010-03-11 JP JP2011553450A patent/JP5667581B2/ja not_active Expired - Fee Related
- 2010-11-03 UA UAA201111801A patent/UA107789C2/ru unknown
-
2011
- 2011-08-18 IL IL214747A patent/IL214747A0/en unknown
- 2011-09-09 TN TN2011000457A patent/TN2011000457A1/fr unknown
- 2011-09-12 CL CL2011002260A patent/CL2011002260A1/es unknown
- 2011-09-12 CO CO11117849A patent/CO6430497A2/es not_active Application Discontinuation
- 2011-09-13 EC EC2011011323A patent/ECSP11011323A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012520446A5 (cg-RX-API-DMAC7.html) | ||
| Yang et al. | Uric acid induced inflammatory responses in endothelial cells via up-regulating (pro) renin receptor | |
| Wang et al. | Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein | |
| Zhang et al. | Linc‐MAF‐4 regulates Th1/Th2 differentiation and is associated with the pathogenesis of multiple sclerosis by targeting MAF | |
| JP2016500110A5 (cg-RX-API-DMAC7.html) | ||
| RU2017126701A (ru) | Способ детекции нуклеосом, содержащих нуклеотиды | |
| JP2014512006A5 (cg-RX-API-DMAC7.html) | ||
| JP2016118568A5 (cg-RX-API-DMAC7.html) | ||
| JP2009536828A5 (cg-RX-API-DMAC7.html) | ||
| JP6755241B2 (ja) | 新規分子バイオマーカーを使用して慢性閉塞性肺疾患（ｃｏｐｄ）を診断する方法 | |
| JP2013178260A5 (cg-RX-API-DMAC7.html) | ||
| JP2011177182A5 (cg-RX-API-DMAC7.html) | ||
| JP2010539490A5 (cg-RX-API-DMAC7.html) | ||
| RU2010101909A (ru) | Способ выявления или лечения реакции "трансплантат против хозяина" | |
| JunHui et al. | Reduced number and activity of circulating endothelial progenitor cells from patients with hyperhomocysteinemia | |
| Biedermann et al. | Agreement between Coaguchek XS and STA-R Evolution (Hepato Quick) INR results depends on the level of INR | |
| JP5667581B2 (ja) | 治療をモニターするためのバイオマーカーを使用した方法またはシステム | |
| Baggett et al. | Myofibroblast senescence promotes arrhythmogenic remodeling in the aged infarcted rabbit heart | |
| JP2013522589A5 (cg-RX-API-DMAC7.html) | ||
| BR112012005158B8 (pt) | método e aparelho para avaliar um valor representando uma massa ou uma concentração ou um volume de uma substância compreendida por um tecido ou um fluido corpóreo de um paciente, controlador, dispositivo para tratar o sangue de um paciente, e, meio de armazenamento digital | |
| Gong et al. | Tumor microenvironment properties are associated with low CD68-positive cell infiltration and favorable disease-free survival in EGFR-mutant lung adenocarcinoma | |
| JP2013526863A5 (cg-RX-API-DMAC7.html) | ||
| JP2012524537A5 (cg-RX-API-DMAC7.html) | ||
| JP2012521549A5 (cg-RX-API-DMAC7.html) | ||
| Szatmary et al. | Improving the design of the agarose spot assay for eukaryotic cell chemotaxis |